![]() |
Steve Kron, M.D., Ph.D.Primary: Associate Professor, Molecular Genetics and Cell Biology Secondary: Committee on Genetics |
|||||||||||||||||||||||||||||||||||||||||||
|
Education:
Research SummaryDNA damage responses; Phosphoproteomics in cell signaling, diagnostics and drug discovery. The Kron laboratory is a highly collaborative group of cell biologists, geneticists, biochemists and chemists. Our major basic research efforts are directed at 1) dissecting cyclin dependent kinase structure and function in yeast, 2) defining roles for chromatin modifications in DNA damage response, and 3) developing novel mass spectrometry methods for phosphoproteomics and high throughput screening. We also pursue translational projects directed at 1) developing Bcr-Abl assays for diagnostics and antagonists for therapeutics and 2) discovering inhibitors of cellular response to DNA double strand breaks as an approach to radiosensitization.
Selected PublicationsWu, D., Nair-Gill, E.,
Sher, D.A., Parker, L.L., Parker, L.L.,
Schilling, A.B., Kron, S.J.
and Kent, S.B. Optimizing
thiophosphorylation in the presence of competing phosphorylation with
MALDI-TOF-MS detection. J. Proteome
Res.,
4:1863-66, 2005. PubMed
Citation Wysocki,
R., Javaheri,
A., Allard, S., Sha, F., Cote, J. and Kron,
S.J. (2005). Role of
Dot1-dependent histone H3 methylation in G1 and S phase DNA damage
checkpoint
functions of Rad9. Mol.
Cell. Biol., 25:8430-43. PubMed
Citation
Parker,
L. L., Kurutz,
J. W., Kent, S. B. and Kron, S.J.
Control of the yeast cell
cycle with a photocleavable alpha-factor analogue. Angew Chem. Int. Ed.
Engl.,
45:6322-5, 2006. PubMed
Citation
Javaheri, A., Wysocki, R., Jobin-Robitaille, O., Altaf, M., Wysocki, R., Javaheri,
A., Kristjansdottir, K., Sha, F. and Kron,
S.J. CDK Pho85
targets CDK inhibitor Sic1 to relieve yeast G1 checkpoint arrest after
DNA
damage. Nat.
Struct. Mol. Biol., 13:908-914, 2006. PubMed
Citation Updated 9/21/07. |
||||||||||||||||||||||||||||||||||||||||||||